Practice Guidelines for the Management of Bacterial Meningitis
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Abstract
In this guideline, we will review our recommendations for the diagnosis and management of bacterial meningitis.Recommendation categories are shown in table 1.The guideline represents data published through May 2004.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parameters such as CSF protein level, glucose level, and white blood cell (WBC) count may be inconsistent in differentiating viral from bacterial infections and nonspecific to provide treatment direction [9].”
From Clinical utility of a cerebrospinal fluid multiplex PCR meningitis/encephalitis panel in children: a retrospective review of positive results (2026) · cites this paper as [9]
In the citing paper
“The sensitivity of CSF Gram stain is 60% to 80% in patients without antibiotic pretreatment and decreases by 20% with antibiotic pretreatment [9].”
From Clinical utility of a cerebrospinal fluid multiplex PCR meningitis/encephalitis panel in children: a retrospective review of positive results (2026) · cites this paper as [9]
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Red Book: 2024–2027 Report of the Committee on Infectious Diseases
Committee on Infectious Diseases, A. A. O. P. (2024) · doi:10.1542/9781610027359 · Cited by 1,548
Principles and Practice of Infectious Diseases
Larson, H. E. (1980) · Journal of Clinical Pathology · doi:10.1136/jcp.33.9.907-a · Cited by 1,276
Dexamethasone in Adults with Bacterial Meningitis
de Gans, J., & van de Beek, D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021334 · Cited by 1,205
Dexamethasone Therapy for Bacterial Meningitis
Lebel, M. H., Freij, B. J., Syrogiannopoulos, G. A., Chrane, D. F., Hoyt, M. J., Stewart, S. M., Kennard, B. D., Olsen, K. D., & McCracken, G. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810133191502 · Cited by 606
Infections of the Central Nervous System
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-415_1 · Cited by 592
Self-citationOdio, C. M., Faingezicht, I., Paris, M., Nassar, M., Baltodano, A., Rogers, J., Sáez-Llorens, X., Olsen, K. D., & McCragken, G. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105303242201 · Cited by 501 · cited 1×
“There have been 15 published trials on the use of adjunctive dexamethasone in infants and children with bacterial meningitis [49–63].”
Aronin, S. I., Peduzzi, P., & Quagliarello, V. J. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-11_part_1-199812010-00004 · Cited by 486 · cited 4×
“In the recent study in adults cited above [71], only 72% of 108 CSF pneumococcal isolates were submitted for in vitro susceptibility testing, and all were susceptible to penicillin, an unusual finding in the United States and in many areas of the world.”
InfluentialMylonakis, E., Hohmann, E. L., & Calderwood, S. B. (1998) · Medicine · doi:10.1097/00005792-199809000-00002 · Cited by 475 · cited 1×
“The likelihood of having a positive Gram stain result also depends on the specific bacterial pathogen causing meningitis [3, 10]: 90% of cases caused by Streptococcus pneumoniae, 86% of cases caused by Haemophilus influenzae, 75% of cases caused by Neisseria meningitidis, 50% of cases caused by gram-negative bacilli,…”
Current Clinical Topics in Infectious Diseases
(1984) · Archives of Internal Medicine · doi:10.1001/archinte.1984.00350150042013 · Cited by 471
Research works printed but not linked: 3
- American Academy of Pediatrics, 2003, Pneumococcal infections, 490
- Kaufman, 1997, Infections of cerebrospinal fluid shunts, 555
- Kaufman, 1997, Infections of cerebrospinal fluid shunts, 555
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
“Dosing varies greatly between studies, but according to the Infectious Diseases Society of America, 5 mg of polymyxin B or 10 mg of colistin daily is recommended for adults (553).”
BackgroundTunkel, A. R., Glaser, C. A., Bloch, K. C., Sejvar, J. J., Marra, C. M., Roos, K. L., Hartman, B. J., Kaplan, S. L., Scheld, W. M., & Whitley, R. J. (2008) · Clinical Infectious Diseases · doi:10.1086/589747 · Cited by 1,193
“Other empirical antimicrobial agents should be initiated on the basis of specific epidemiologic or clinical factors (tables 2 and 3), including appropriate therapy for presumed bacterial meningitis if clinically indicated [70].”
Self-citationClinical Microbiology and Infection
(2012) · Clinical Microbiology and Infection · doi:10.1016/s1198-743x(14)61044-2 · Cited by 1,103
Tunkel, A. R., Hasbun, R., Bhimraj, A., Byers, K., Kaplan, S. L., Scheld, W. M., van de Beek, D., Bleck, T. P., Garton, H. J. L., & Zunt, J. R. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw861 · Cited by 1,067
Self-citationNau, R., Sörgel, F., & Eiffert, H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00007-10 · Cited by 1,026
“pneumoniae meningitis are scarce, some authors recommended that in areas with high rates of occurrence of penicillin-resistant pneumococcal strains, the combination of ceftriaxone plus rifampin instead of vancomycin should be preferred, or rifampin, vancomycin, and ceftriaxone should be administered together when adju…”
BackgroundBacterial Meningitis in the United States, 1998–2007
Thigpen, M. C., Whitney, C. G., Messonnier, N. E., Zell, E. R., Lynfield, R., Hadler, J. L., Harrison, L. H., Farley, M. M., Reingold, A., Bennett, N. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005384 · Cited by 953
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930
“Therefore, empirical therapy should include vancomycin, an expanded-spectrum cephalosporin, and ampicillin (311, 320).”
BackgroundInfluentialSelf-citationESCMID guideline: diagnosis and treatment of acute bacterial meningitis
van de Beek, D., Cabellos, C., Dzupova, O., Esposito, S., Klein, M., Kloek, A. T., Leib, S. L., Mourvillier, B., Ostergaard, C., Pagliano, P., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.007 · Cited by 919
General Principles of Antimicrobial Therapy
Leekha, S., Terrell, C. L., & Edson, R. S. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0639 · Cited by 878
“For example, in an otherwise healthy young adult with suspected bacterial meningitis who is seen in the emergency department, the most likely pathogens would be and , and thus a combination of a third-generation cephalosporin (ceftriaxone) plus vancomycin would be recommended as empiric therapy.(5) Hospital-acquired i…”
BackgroundKyaw, M. H., Lynfield, R., Schaffner, W., Craig, A. S., Hadler, J., Reingold, A., Thomas, A. R., Harrison, L. H., Bennett, N. M., Farley, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051642 · Cited by 881
Community-Acquired Bacterial Meningitis in Adults
van de Beek, D., de Gans, J., Tunkel, A. R., & Wijdicks, E. F. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052116 · Cited by 880
Self-citationMiller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy381 · Cited by 641
“Early, incorrect assumptions held that selected antigen tests on CSF may have some value in patients who received therapy prior to specimen collection with negative Gram stain and negative culture results [22], but this is no longer recommended.”
BackgroundO’Grady, N. P., Barie, P. S., Bartlett, J. G., Bleck, T., Carroll, K., Kalil, A. C., Linden, P., Maki, D. G., Nierman, D., Pasculle, W., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318169eda9 · Cited by 600
Baron, E. J., Miller, J. M., Weinstein, M. P., Richter, S. S., Gilligan, P. H., Thomson, R. B., Bourbeau, P., Carroll, K. C., Kehl, S. C., Dunne, W. M., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit278 · Cited by 592
“Bacterial antigen testing on CSF is not recommended but may have some value in patients who received therapy prior to specimen collection with negative Gram stain and negative culture results [14].”
BackgroundWilson, W. R., Bower, T. C., Creager, M. A., Amin-Hanjani, S., O’Gara, P. T., Lockhart, P. B., Darouiche, R. O., Ramlawi, B., Derdeyn, C. P., Bolger, A. F., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000457 · Cited by 572
Charlier, C., Perrodeau, É., Leclercq, A., Cazenave, B., Pilmis, B., Henry, B., Lopes, A., Maury, M. M., Moura, A., Goffinet, F., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30521-7 · Cited by 581
Bacterial meningitis in children
Sáez-Llorens, X., & McCracken, G. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13693-8 · Cited by 533
“Current recommendations support the use of dexamethasone in infants and children with Hib meningitis [55].”
BackgroundMethodInfluentialEffect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis
Hsu, H. E., Shutt, K. A., Moore, M. R., Beall, B. W., Bennett, N. M., Craig, A. S., Farley, M. M., Jorgensen, J. H., Lexau, C. A., Petit, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0800836 · Cited by 497
Pathogenesis and Pathophysiology of Pneumococcal Meningitis
Mook-Kanamori, B. B., Geldhoff, M., van der Poll, T., & van de Beek, D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-11 · Cited by 492
Antimicrobial Resistance in Haemophilus influenzae
Tristram, S., Jacobs, M. R., & Appelbaum, P. C. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-06 · Cited by 464
“A fluoroquinolone, either gatifloxacin or moxifloxacin, can be added to the list of recommended alternative agents for adult patients only (146).”
BackgroundInfluentialAcute bacterial meningitis in infants and children
Kim, K. S. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70306-8 · Cited by 454
Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients
Cook, A. M., Morgan Jones, G., Hawryluk, G. W. J., Mailloux, P., McLaughlin, D., Papangelou, A., Samuel, S., Tokumaru, S., Venkatasubramanian, C., Zacko, C., et al. (2020) · Neurocritical Care · doi:10.1007/s12028-020-00959-7 · Cited by 447
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy584 · Cited by 449
“Early, incorrect assumptions held that selected antigen tests on CSF may have some value in patients who received therapy prior to specimen collection with negative Gram stain and negative culture results [22], but this is no longer recommended.”
BackgroundNosocomial Bacterial Meningitis
van de Beek, D., Drake, J. M., & Tunkel, A. R. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0804573 · Cited by 433
Self-citationMiller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gonzalez, M. D., Harrington, A., Jerris, R. C., Kehl, S. C., Leal, S. M., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae104 · Cited by 376
Challenges in the diagnosis and management of neonatal sepsis
Zea-Vera, A., & Ochoa, T. J. (2015) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmu079 · Cited by 385
“Considering the lack of high-quality evidence and the poor understanding of the effect of steroids on the developing brain, adjunctive dexamethasone is not recommended in neonatal meningitis [77].”
BackgroundInfluentialPrevention and Treatment of Cancer-Related Infections
Baden, L. R., Bensinger, W., Angarone, M., Casper, C., Dubberke, E. R., Freifeld, A. G., Garzon, R., Greene, J. N., Greer, J. P., Ito, J. I., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0146 · Cited by 368
Treatment of Acinetobacter Infections
Fishbain, J., & Peleg, A. Y. (2010) · Clinical Infectious Diseases · doi:10.1086/653120 · Cited by 358
“The dosing recommended by the Infectious Diseases Society of America for adults is 10 mg daily of colistin or 5 mg daily of polymyxin B [27].”
Advances in treatment of bacterial meningitis
van de Beek, D., Brouwer, M. C., Thwaites, G. E., & Tunkel, A. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61186-6 · Cited by 336
Self-citationCommunity-acquired bacterial meningitis
van de Beek, D., Brouwer, M., Hasbun, R., Koedel, U., Whitney, C. G., & Wijdicks, E. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.74 · Cited by 312
“Dexamethasone is the only adjunctive therapy that has been advocated by the IDSA and ESCMID guidelines 109,151 .”
BackgroundInfluentialSyndromic Panel-Based Testing in Clinical Microbiology
Ramanan, P., Bryson, A. L., Binnicker, M. J., Pritt, B. S., & Patel, R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00024-17 · Cited by 308
“Traditionally, the laboratory diagnosis of bacterial meningitis has been made by using Gram staining and culture of CSF, with molecular testing for herpes simplex virus 1 (HSV-1), HSV-2, and enterovirus, in particular, playing an important role in the diagnosis of viral CNS infections (73, 74).”
MethodWeisfelt, M., van de Beek, D., Spanjaard, L., Reitsma, J. B., & de Gans, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70288-x · Cited by 313
Koopmans, M. M., Brouwer, M. C., Vázquez-Boland, J. A., & van de Beek, D. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00060-19 · Cited by 293
“Macrolides Erythromicin Bacteriostatic (478) Yes (480) Limited (507) Limited (477) Meropenem (273, 483, 497) Bacteriocidal (483, 554) Yes (554) Limited (555) Yes (556) Penicillin Bacteriostatic (478) Limited (478) Yes (504) Limited (501)”
BackgroundDiagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department
Liu, B., Chen, Y.-X., Yin, Q., Zhao, Y.-Z., & Li, C.-S. (2013) · Critical Care · doi:10.1186/cc13070 · Cited by 299
“Determination of bacterial meningitis was based on compatible clinical features, and cerebrospinal fluid findings (cerebrospinal fluid leukocyte count >1,000/mm(3)) [12].”
BackgroundImpact of Reported Beta-Lactam Allergy on Inpatient Outcomes: A Multicenter Prospective Cohort Study
MacFadden, D. R., LaDelfa, A., Leen, J., Gold, W. L., Daneman, N., Weber, E., Al-Busaidi, I., Petrescu, D., Saltzman, I., Devlin, M., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw462 · Cited by 296
Community-acquired bacterial meningitis.
van de Beek, D., Brouwer, M. C., Koedel, U., & Wall, E. C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00883-7 · Cited by 292
A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City
Frontera, J. A., Sabadia, S., Lalchan, R., Fang, T., Flusty, B., Millar-Vernetti, P., Snyder, T., Berger, S., Yang, D., Granger, A., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000010979 · Cited by 291
“Seizure/epilepsy 89/606 (15) 124/3,885 (3) <0.”
Corticosteroids for Bacterial Meningitis in Adults in Sub-Saharan Africa
Scarborough, M., Gordon, S. B., Whitty, C. J. M., French, N., Njalale, Y., Chitani, A., Peto, T. E. A., Lalloo, D. G., & Zijlstra, E. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065711 · Cited by 281
Bundled care for septic shock: An analysis of clinical trials*
Barochia, A. V., Cui, X., Vitberg, D., Suffredini, A. F., OʼGrady, N. P., Banks, S. M., Minneci, P., Kern, S. J., Danner, R. L., Natanson, C., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cb0ddf · Cited by 279
Acute bacterial meningitis in adults
McGill, F., Heyderman, R. S., Panagiotou, S., Tunkel, A. R., & Solomon, T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30654-7 · Cited by 274
Self-citationTansarli, G. S., & Chapin, K. C. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.016 · Cited by 263
McGill, F., Heyderman, R. S., Michael, B. D., Defres, S., Beeching, N. J., Borrow, R., Glennie, L., Gaillemin, O., Wyncoll, D., Kaczmarski, E., et al. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.01.007 · Cited by 254
Progress and Challenges in Bacterial Meningitis: A Review
Hasbun, R. (2022) · JAMA · doi:10.1001/jama.2022.20521 · Cited by 247
Meropenem: A Review of its Use in the Treatment of Serious Bacterial Infections
Baldwin, C. M., Lyseng-Williamson, K. A., & Keam, S. J. (2008) · Drugs · doi:10.2165/00003495-200868060-00006 · Cited by 247
Castelblanco, R. L., Lee, M., & Hasbun, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70805-9 · Cited by 245
Clinical use of anti-TNF therapy and increased risk of infections
Ali, T., Bronze, Kaitha, Mahmood, Ftaisi, & Stone (2013) · Drug, Healthcare and Patient Safety · doi:10.2147/dhps.s28801 · Cited by 242
“Adjunctive therapy with dexamethasone (10 mg IV every 6 hours for 4 days) should be considered in all cases of pneumococcal meningitis.(39) Prevention of pneumococcal infection is largely accomplished through vaccination.”
Management of meningitis due to antibiotic-resistant Acinetobacter species
Kim, B.-N., Peleg, A. Y., Lodise, T. P., Lipman, J., Li, J., Nation, R., & Paterson, D. L. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70055-6 · Cited by 244
Auburtin, M., Wolff, M., Charpentier, J., Varon, E., Le Tulzo, Y., Girault, C., Mohammedi, I., Renard, B., Mourvillier, B., Bruneel, F., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000239434.26669.65 · Cited by 245
“Standard reference sources and the most recently published guidelines have recommended that patients with purulent meningitis be given the first antibiotic dose as soon as possible, even before CSF has been drawn via lumbar puncture (19).”
BackgroundRifampin Combination Therapy for Nonmycobacterial Infections
Forrest, G. N., & Tamura, K. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-09 · Cited by 242
“pneumoniae isolate and only if the isolate is known to be susceptible to rifampin (247).”
BackgroundAdjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data
van de Beek, D., Farrar, J. J., de Gans, J., Mai, N. T. H., Molyneux, E. M., Peltola, H., Peto, T. E., Roine, I., Scarborough, M., Schultsz, C., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70023-5 · Cited by 241
Mycobacterium avium in the Postgenomic Era
Turenne, C. Y., Wallace, R., & Behr, M. A. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-06 · Cited by 226
Egi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Journal of Intensive Care · doi:10.1186/s40560-021-00555-7 · Cited by 224
Logan, S. A. E., & MacMahon, E. (2008) · BMJ · doi:10.1136/bmj.39409.673657.ae · Cited by 219
Bacterial Meningitis in Children
Chávez-Bueno, S., & McCracken, G. H. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2005.02.011 · Cited by 204
“8 mg/kg daily in two or three divided doses for 2 days to 1 mg/kg in four divided doses for 2 to 4 days [41,55].”
BackgroundMethodInfluentialFrontera, J. A., Yang, D., Lewis, A., Patel, P., Medicherla, C., Arena, V., Fang, T., Andino, A., Snyder, T., Madhavan, M., et al. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117486 · Cited by 203
Systematic review: neonatal meningitis in the developing world
Furyk, J. S., Swann, O., & Molyneux, E. (2011) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2011.02750.x · Cited by 202
Rice, L. B. (2008) · Clinical Infectious Diseases · doi:10.1086/526535 · Cited by 200
Induced Hypothermia in Severe Bacterial Meningitis: A Randomized Clinical Trial
Mourvillier, B., Tubach, F., van de Beek, D., Garot, D., Pichon, N., Georges, H., Lefevre, L. M., Bollaert, P.-E., Boulain, T., Luis, D., et al. (2013) · JAMA · doi:10.1001/jama.2013.280506 · Cited by 199
Intracranial Microbial Aneurysm (Infectious Aneurysm): Current Options for Diagnosis and Management
Kannoth, S., & Thomas, S. V. (2009) · Neurocritical Care · doi:10.1007/s12028-009-9208-x · Cited by 195
“been negative. In such instances, antibiotics are selected according to the CSF profile and clinical features as in other cases of meningitis [ 34 ].”
BackgroundMcGill, F., Griffiths, M. J., Bonnett, L. J., Geretti, A. M., Michael, B. D., Beeching, N. J., McKee, D., Scarlett, P., Hart, I. J., Mutton, K. J., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30245-7 · Cited by 193
Polymyxin B: similarities to and differences from colistin (polymyxin E)
Kwa, A., Kasiakou, S. K., Tam, V. H., & Falagas, M. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.5.811 · Cited by 190
Emergency diagnosis and treatment of adult meningitis
Fitch, M. T., & van de Beek, D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70050-6 · Cited by 189
Glimaker, M., Johansson, B., Grindborg, O., Bottai, M., Lindquist, L., & Sjolin, J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ011 · Cited by 190
“In 2004, the Swedish guidelines for ABM were revised, mainly according to the Infectious Diseases Society of America guidelines [19].”
MethodReview: Pathophysiology and treatment of bacterial meningitis
Hoffman, O., & Weber, J. R. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285609337975 · Cited by 179
“The data for treatment durations are very limited and mostly based on expert opinion [Tunkel et al. 2004].”
MethodProspects for Vaccine Prevention of Meningococcal Infection
Harrison, L. H. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.142-164.2006 · Cited by 178
“More extensive general reviews of the clinical manifestations and therapy of meningococcal disease and bacterial meningitis can be found elsewhere (10, 354, 355).”
BackgroundEpidemiology of meningitis and encephalitis in the United States, 2011–2014
Hasbun, R., Rosenthal, N., Balada-Llasat, J. M., Chung, J., Duff, S., Bozzette, S., Zimmer, L., & Ginocchio, C. C. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix319 · Cited by 171
Post–Dural Puncture Bacterial Meningitis
Baer, E. T., & Warltier, D. C. (2006) · Anesthesiology · doi:10.1097/00000542-200608000-00022 · Cited by 173
“The concomitant administration of steroids and vancomycin probably results in lower CSF levels of vancomycin, because the increased antiinflammatory effect of the steroids lessens the penetration of vancomycin into the CSF.(98) Vancomycin is not recommended as the sole antimicrobial but rather in combination.”
BackgroundResultInfluentialAntibiotic treatment delay and outcome in acute bacterial meningitis
Køster-Rasmussen, R., Korshin, A., & Meyer, C. N. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.09.033 · Cited by 172
Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis
Brouwer, M. C., Heckenberg, S. G. B., de Gans, J., Spanjaard, L., Reitsma, J. B., & van de Beek, D. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f96297 · Cited by 172
“Hearing impairment 33/280 (12) 55/243 (22) 10 0.”
BackgroundPharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing
Onufrak, N. J., Forrest, A., & Gonzalez, D. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.06.015 · Cited by 170
Task force on management and prevention of Acinetobacter baumannii infections in the ICU
Garnacho-Montero, J., Dimopoulos, G., Poulakou, G., Akova, M., Cisneros, J. M., De Waele, J., Petrosillo, N., Seifert, H., Timsit, J. F., Vila, J., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-4079-4 · Cited by 167
Tsai, C. J., Griffin, M. R., Nuorti, J. P., & Grijalva, C. G. (2008) · Clinical Infectious Diseases · doi:10.1086/587897 · Cited by 167
“distribution of pneumococcal meningitis continues to change after implementation of PCV7, it might be necessary to reevaluate prevalent pathogens and current age-based empirical treatment recommendations for bacterial meningitis [28].”
BackgroundKaraiskos, I., Galani, L., Baziaka, F., & Giamarellou, H. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.02.006 · Cited by 166
“Regarding treatment options, removal of the external catheter increases the chance of infection cure, whereas for shunt devices the most effective treatment includes removal of the shunt, implantation of a temporary external device in combination with appropriate parenteral and local antibiotic treatment, leading to a…”
BackgroundInfluentialIncreasing Vancomycin Serum Trough Concentrations and Incidence of Nephrotoxicity
Pritchard, L., Baker, C., Leggett, J., Sehdev, P., Brown, A., & Bayley, K. B. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.07.025 · Cited by 161
Consequences of avoiding β-lactams in patients with β-lactam allergies
Jeffres, M. N., Narayanan, P. P., Shuster, J. E., & Schramm, G. E. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.026 · Cited by 154
Dubos, F., Korczowski, B., Aygun, D. A., Martinot, A., Prat, C., Galetto-Lacour, A., Casado-Flores, J., Taskin, E., Leclerc, F., Rodrigo, C., et al. (2008) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.162.12.1157 · Cited by 153
Strich, J. R., Heil, E. L., & Masur, H. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa221 · Cited by 188
“Meningitis [22] Vancomycin and cefepime, ceftazidime or”
Falagas, M. E., Bliziotis, I. A., & Tam, V. H. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.024 · Cited by 151
“Guidelines published by the Infectious Diseases Society of America (IDSA) in 2004 suggest that the intraventricular dosage of polymyxin B should be 2 mg in children and 5 mg in adults, whereas the dosage of colistin should be 10 mg [ 61 ].”
BackgroundRivera, A. M., & Boucher, H. W. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0514 · Cited by 178
The diagnosis and management of acute bacterial meningitis in resource-poor settings
Scarborough, M., & Thwaites, G. E. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70139-x · Cited by 167
Thomson, A. H., Staatz, C. E., Tobin, C. M., Gall, M., & Lovering, A. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp085 · Cited by 151
Viallon, A., Desseigne, N., Marjollet, O., Birynczyk, A., Belin, M., Guyomarch, S., Borg, J., Pozetto, B., Bertrand, J. C., & Zeni, F. (2011) · Critical Care · doi:10.1186/cc10254 · Cited by 150
“The emergency therapeutic management of meningitis involves rapid identification of the bacterial or viral nature of this disease, so that antibiotic treatment can be started without delay [1], even though the relation between prognosis and delay in starting antibiotic therapy has not been clearly established [2-5].”
BackgroundSeizures in adults with bacterial meningitis
Zoons, E., Weisfelt, M., de Gans, J., Spanjaard, L., Koelman, J. H. T. M., Reitsma, J. B., & van de Beek, D. (2008) · Neurology · doi:10.1212/01.wnl.0000288178.91614.5d · Cited by 145
Cephalosporins: A Focus on Side Chains and β-Lactam Cross-Reactivity
Chaudhry, S. B., Veve, M. P., & Wagner, J. L. (2019) · Pharmacy · doi:10.3390/pharmacy7030103 · Cited by 197
“It can also be used as alternative therapy for community-acquired meningitis, and as definitive therapy for vertebral osteomyelitis and culture-negative infective endocarditis [29,36,54].”
BackgroundPneumococcal meningitis in adults: new approaches to management and prevention
Weisfelt, M., de Gans, J., van der Poll, T., & van de Beek, D. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70409-4 · Cited by 153
Moja, L., Zanichelli, V., Mertz, D., Gandra, S., Cappello, B., Cooke, G., Chuki, P., Harbarth, S., Pulcini, C., Mendelson, M., et al. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.02.003 · Cited by 177
Heckenberg, S. G. B., de Gans, J., Brouwer, M. C., Weisfelt, M., Piet, J. R., Spanjaard, L., van der Ende, A., & van de Beek, D. (2008) · Medicine · doi:10.1097/md.0b013e318180a6b4 · Cited by 142
Ricard, J.-D., Wolff, M., Lacherade, J.-C., Mourvillier, B., Hidri, N., Barnaud, G., Chevrel, G., Bouadma, L., & Dreyfuss, D. (2007) · Clinical Infectious Diseases · doi:10.1086/510390 · Cited by 143
“In addition, patients treated in one of the centers received intravenous rifampin at a dose of 20 mg per kg of body weight per day, as recently suggested [14, 15].”
BackgroundMethodInfluentialMeningococcal disease: changes in epidemiology and prevention
Stephens, D. S., Chang, Q., & Tzeng (2012) · Clinical Epidemiology · doi:10.2147/clep.s28410 · Cited by 167
“meningitidis immediately is the primary goal of treating infected individuals.(4) Due to the potential for contact and epidemic spread, rapid onset, high case-fatality rate, and neurologic sequelae of meningococcal disease, a single case elicits an immediate public health response.”
Epidemiology, Prevention and Management of Ventriculoperitoneal Shunt Infections in Children
Prusseit, J., Simon, M., von der Brelie, C., Heep, A., Molitor, E., Völz, S., & Simon, A. (2009) · Pediatric Neurosurgery · doi:10.1159/000257520 · Cited by 142
“Coagulase-negative staphylococci (CoNS) have been detected in 17–78p of the cases (table 2 ), and Staphylococcus epidermidis accounts for 47–64p of all Gram-positive VPS infections [”
BackgroundUpdate in the Diagnosis and Management of Central Nervous System Infections
Ziai, W., & Lewin, J. J. (2008) · Neurologic Clinics · doi:10.1016/j.ncl.2008.03.013 · Cited by 147
“In patients who improve with antimicrobial therapy, repeat LP and CSF analysis to document CSF sterilization is not indicated routinely [82].”
BackgroundInfluentialIntracerebroventricular Administration of Drugs
Cook, A. M., Mieure, K. D., Owen, R. D., Pesaturo, A. B., & Hatton, J. (2009) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.7.832 · Cited by 137
“Although the pharmacokinetics may suggest that vancomycin is not an ideal antimicrobial for brain infections, most clinical evidence suggests that systemic administration of vancomycin is effective and it continues to be recommended for empiric coverage of many different types of brain infections.(47) However, clinica…”
BackgroundMethodStrategies for Reduction in Duration of Antibiotic Use in Hospitalized Patients
Hayashi, Y., & Paterson, D. L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir063 · Cited by 147
“7–21 days, depending on the organism (Table 2) [31].”
BackgroundManagement of post-neurosurgical meningitis: narrative review
Hussein, K., Bitterman, R., Shofty, B., Paul, M., & Neuberger, A. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.05.013 · Cited by 142
Choice and Duration of Antimicrobial Therapy for Neonatal Sepsis and Meningitis
Sivanandan, S., Soraisham, A. S., & Swarnam, K. (2011) · International Journal of Pediatrics · doi:10.1155/2011/712150 · Cited by 148
“In 2004, Infectious Disease Society of America published practice guidelines for treatment of meningitis [56].”
BackgroundInfluentialReinhart, K., Brunkhorst, F. M., Bone, H.-G., Bardutzky, J., Dempfle, C.-E., Forst, H., Gastmeier, P., Gerlach, H., Gründling, M., John, S., et al. (2010) · BORIS (University Library Bern) · doi:10.48350/654 · Cited by 137
Saxena, M., Young, P., Pilcher, D., Bailey, M., Harrison, D., Bellomo, R., Finfer, S., Beasley, R., Hyam, J., Menon, D., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3676-6 · Cited by 135
“However there remains clinical uncertainty about the biological purpose of fever [10, 11] and the therapeutic efficacy of the interventions [7, 12–14] used for fever suppression in these patient populations.”
BackgroundCefepime: a reappraisal in an era of increasing antimicrobial resistance
Endimiani, A., Pérez, F., & Bonomo, R. A. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.6.805 · Cited by 137
“25 10 0 [1 42 ]”
BackgroundInfluentialEmergence of Ciprofloxacin-Resistant Neisseria meningitidis in North America
Wu, H. M., Harcourt, B. H., Hatcher, C. P., Wei, S. C., Novak, R. T., Wang, X., Juni, B. A., Glennen, A., Boxrud, D. J., Rainbow, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806414 · Cited by 135
Metadata
- Authors
- Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J.
- Affiliations
- Drexel University (US)
- Weill Cornell Medical Center (US)
- Baylor College of Medicine (US)
- Medical College of Wisconsin (US)
- Indiana University School of Medicine (US)
- University of Virginia (US)
- University of Alabama at Birmingham (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-11-01
- Volume
- 39
- Issue
- 9
- Pages
- 1267-1284
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2143206150
- Cited by
- 2,308
- References
- 137
- Citations by year
- 2026: 111 · 2025: 99 · 2024: 101 · 2023: 83 · 2022: 115 · 2021: 131 · 2020: 125 · 2019: 128 · 2018: 116 · 2017: 142 · 2016: 121 · 2015: 142 · 2014: 102 · 2013: 128 · 2012: 117
- FWCI
- 44.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- bacterial meningitis, diagnosis, management, antimicrobial therapy, clinical guidelines
- MeSH terms
- Adult, Algorithms, Anti-Bacterial Agents, Cerebrospinal Fluid Shunts, Child, Humans, Infant, Infant, Newborn, Meningitis, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.